Biocon Biologics Malaysia- Walk in Alert for multiple positions on 25th and 26th November 2022
WalkinAlert for Malaysia: Biocon Biologics Malaysia – Asia’s largest integrated insulins facility that manufactures Drug Substance and Drug Products, is hiring professionals for multiple positions for its facility in Johor (Malaysia).
If you have relevant industry experience in Biomedical, Biotechnology, Chemistry, Engineering – Chemical, Bioprocess Engineering, Food Technology/Nutrition, Healthcare – Pharmacy, Science & Technology/Laboratory, then gear up to attend our 𝐰𝐚𝐥𝐤-𝐢𝐧-𝐢𝐧𝐭𝐞𝐫𝐯𝐢𝐞𝐰 𝐚𝐭 𝐁𝐢𝐨𝐜𝐨𝐧 𝐒𝐝𝐧 𝐁𝐡𝐝, 𝐌𝐚𝐥𝐚𝐲𝐬𝐢𝐚, 𝐨𝐧 𝟐𝟓𝐭𝐡 𝐚𝐧𝐝 𝟐𝟔𝐭𝐡 𝐨𝐟 𝐍𝐨𝐯𝐞𝐦𝐛𝐞𝐫, 𝟐𝟎𝟐𝟐.
𝑨𝒃𝒐𝒖𝒕 𝑩𝒊𝒐𝒄𝒐𝒏 𝑩𝒊𝒐𝒍𝒐𝒈𝒊𝒄𝒔 𝑴𝒂𝒍𝒂𝒚𝒔𝒊𝒂:
The Biocon Biologics facility in Malaysia is a Center of Excellence (CoE) for insulins in Malaysia with end-to-end capabilities to manufacture a broad portfolio of regular, basal, and rapid insulins. The state-of-the-art insulins facility in Johor is the first and only biopharmaceutical sterile injectables facility in Malaysia to receive U.S. Food and Drug Administration (FDA) and European Medicines Agency approvals. More recently, Biocon’s biosimilar insulin Glargine made in Malaysia received a historic U.S. FDA approval as the ‘first interchangeable biosimilar’.
The 562,000 sq. ft. facility has been recognized as the first and largest integrated insulin manufacturer in Malaysia by the prestigious Malaysia Book of Records, which officially recognizes record-creating and record-breaking achievements in the fields of human endeavor, building & structures, transportation, arts & entertainment, business, sports & games, science & technology, nature, etc. in Malaysia.